TIL Therapy Provides Excitement Despite Room to Grow in Melanoma Care
Written by
Cancer Network
Published
0
comments
0
min
At 4 years, about 20% of patients with advanced melanoma who received tumor-infiltrating lymphocyte therapy were alive and responding to treatment.